CONTRATO
Contract L338
Desarrollo de comprimidos de liberacion sostenida de un antidepresivo.
Funder: NEURAXPHARM ARZNEIMITTEL GMBH
Call: (NEURAXPHARM ARZNEIMITTEL GMBH)
date_range
Duration: from 09 June 2017 to 11 March 2019
(21 months)
Finished
€163,400.00
Of European scope.
